Article
DNA repair gene polymorphisms and benefit from gefitinib in never‐smokers with lung adenocarcinoma
24 Jan 2011
Abstract excerpt
BACKGROUND: The objective of this study was to investigate whether polymorphisms in DNA repair genes affect clinical outcome of never-smokers with lung adenocarcinoma (NSLA). METHOD: Common polymorphisms in the DNA repair genes ribonucleotide reductase M1 (RRM1), excision repair cross-complementation group 1 (ERCC1), and x-ray repair cross-complementing group 1 (XRCC1) were genotyped in DNA samples from 158...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
